Back
Vanda Pharmaceuticals Vs. Edgewise Therapeutics Industry Stock Comparison
Sell
23
VNDA
Vanda Pharmaceuticals
Last Price:
4.62
Seasonality Move:
8.6%
Buy
70
EWTX
Edgewise Therapeutics
Last Price:
28.38
Seasonality Move:
22.45%
Sell
23
Vanda Pharmaceuticals (VNDA)
is a Sell
Is Vanda Pharmaceuticals a Buy, Sell or Hold?
- The current Vanda Pharmaceuticals [VNDA] share price is $4.63. The Score for VNDA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- VNDA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $28.40. The Score for EWTX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VNDA Stock Price Chart
What is Vanda Pharmaceuticals's stock price today?
-
The Vanda Pharmaceuticals share price today is $4.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VNDA is experiencing slight buying pressure.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $28.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
VNDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 40.12 | Sell |
| Chaikin Money Flow: | 67272 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.66 - 5.08) | Sell |
| Bollinger Bands (100): | (4.9 - 5.92) | Sell |
EWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.35 | Buy |
| Relative Strength Index (14 RSI): | 69.1 | Buy |
| Chaikin Money Flow: | 1141751 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.56 - 26.94) | Buy |
| Bollinger Bands (100): | (16.15 - 22.69) | Buy |
VNDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.65 | Sell |
| 20-day SMA: | 4.81 | Sell |
| 50-day SMA: | 5.13 | Sell |
| 200-day SMA: | 4.82 | Sell |
| 8-day EMA: | 4.64 | Sell |
| 20-day EMA: | 4.8 | Sell |
| 50-day EMA: | 5.06 | Sell |
| 200-day EMA: | 5.12 | Sell |
EWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.78 | Buy |
| 20-day SMA: | 23.33 | Buy |
| 50-day SMA: | 20.1 | Buy |
| 200-day SMA: | 17.66 | Buy |
| 8-day EMA: | 26.71 | Buy |
| 20-day EMA: | 24.35 | Buy |
| 50-day EMA: | 21.63 | Buy |
| 200-day EMA: | 17.43 | Buy |
Vanda Pharmaceuticals Earnings Growth & VNDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.35 per share.
Vanda Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Edgewise Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||